• image 01
    Volume 1, No.1, 2012
  • image 02
    Volume 1, No.2, 2012
  • image 01
    Volume 1, No.3, 2012
  • image 02
    Volume 2, No.1, 2013
  • image 02
    Volume 2, No.2, 2013
  • image 02
    Volume 2, No.S1, 2013
  • image 02
    Volume 2, No.3, 2013
  • image 02
    Volume 2, No.4, 2013
  • image 02
    Volume 3, No.1, 2014
  • image 02
    Volume 3, No.2, 2014
  • Volume 3, No3
    Volume 3, No.3, 2014
  • Volume 3, No4
    Volume 3, No.4, 2014
  • Volume 4, No1
    Volume 4, No.1, 2015
  • Volume 4, No2
    Volume 4, No.2, 2015
  • Volume 4, No3
    Volume 4, No.3, 2015
  • Volume 4, No4
    Volume 4, No.4, 2015
  • Volume 5, No1
    Volume 5, No.1, 2016
  • image 01
  • image 02
  • Login|Register
  • Chem Sci Trans., 2014, 3(2),  pp 708-716  

    DOI:10.7598/cst2014.739

    Research Article

    G-QSAR of Novel 2-{[2-(1H-imidazol-1-yl)ethyl]sulfanyl}-1H-benzimidazole Derivatives

  • MAYURA KALE, GAJANAN SONWANE and RAJESH NAWALE
  • Department of Pharmaceutical Chemistry, Government College of Pharmacy, Osmanpura, Aurangabad, Maharashtra, India
  • Abstract

    In the present work, we have applied group quantitative structure–activity relationships (G-QSAR) for exploring the relationship between the structures of a new emerging family of 2-{[2-(1H-imidazol-1-yl)ethyl]sulfanyl}-1H-benzimidazole derivatives and their antiprotozoal activities. We have developed descriptive models, in order to aid in further optimization and development of newer antiprotozoal agents containing the benzimidazole pharmacophore. G-QSAR was performed on VLife molecular design suite (MDS) 4.5 version software. The predictive power of the QSAR was checked through the cross validation technique and also by leaving some compounds as part of external test set

    Keywords

    GQSAR, Benzimidazole, Antiprotozoal activity, Model generation

    This article has been viwed 1884 times

      

    Citations for this article 0

      

    No Citations